Anti-VEGF: Looking Forward in Lung Cancer
CME Monograph
July 2007
Table of Contents
Issues and Opportunities in Treating Lung Cancer Today
Thomas J. Lynch, Jr., MD
Massachusetts General Hospital Cancer Center
Rationale for VEGF as a Target in Lung Cancer
Rebecca Suk Heist, MD, MPH
Massachusetts General Hospital Cancer Center
Monoclonal Antibody-based Anti-VEGF Therapy
Tracey L. Evans, MD
University of Pennsylvania School of Medicine
Receptor Tyrosine Kinase Inhibitors of VEGF
Mark A. Socinski, MD
University of North Carolina, Chapel Hill
Combination VEGF/EGFR Therapies
Edward S. Kim, MD
The University of Texas MD Anderson Cancer Center
